Lomond Therapeutics Holdings, Inc.
Clinical trials sponsored by Lomond Therapeutics Holdings, Inc., explained in plain language.
-
New drug ZE46-0134 tested in healthy people for first time
Knowledge-focused CompletedThis study tested a new drug called ZE46-0134 in 112 healthy adults to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. This early research helps doctors understand the right dose and any side effects before testing…
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:50 UTC
-
New drug ZE50-0134 put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a new drug called ZE50-0134 in 104 healthy adults aged 18 to 55. The main goal was to check if the drug is safe and how the body processes it, not to treat any disease. Participants took single or multiple doses of the drug or a placebo, and some als…
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:34 UTC